Open access
Jul 2026
Siglec-1-targeted nanobodies restrict HIV-1 transmission and infection of dendritic cells
Newly developed single-domain antibodies against Siglec-1 are used against Siglec-1 as a candidate inhibitor to limit HIV-1 transmission and support the development of host-directed nanobody-based strategies to reduce HIV-1 spread.
S. Man, A. Affandi, H. Brink et al.
· Journal of Virology · 0 citations